Sept. 25, 2018 (GLOBE NEWSWIRE) -- RavenQuest BioMed Inc. (the “Company” or “RavenQuest”) – (CSE: RQB OTCQB: RVVQF Frankfurt: 1IT) is excited to provide a full update on milestones achieved and strategic initiatives undertaken as the Company prepares for legalization on October 17, 2018. We’ve signed a major supply agreement with the Province of British Columbia, we’ll have two facilities in major markets running at full capacity by year’s end, we’re rapidly expanding our capacity, executing on new agreements with Indigenous communities, launching two attractive new brands and building out a craft grow division to supply boutique brands to discerning consumers.
Read more
RavenQuest Provides Corporate Update
